| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1913 |
| Trial ID | NCT03573700 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SJCAR19|CD19 CAR-T cells |
| Co-treatment | Mesna |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia |
| Year | 2018 |
| Country | United States |
| Company sponsor | St. Jude Children's Research Hospital |
| Other ID(s) | SJCAR19|NCI-2017-01399 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||